CD147 stimulates HIV-1 infection in a signal-independent fashion

Biochemical and Biophysical Research Communications

Volumn 363, Issue 3, 2007, Pages 495-499

  Pushkarsky, Tatiana ^a   Yurchenko, Vyacheslav ^b   Laborico, Alicia ^a   Bukrinsky, Michael ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CD147; Co factor; Cyclophilin A; Cytoplasmic domain; ERK; HIV 1; Replication; Signaling

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD147; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; CYCLOPHILIN A; ENZYME ACTIVATION; FLAVONOIDS; FLOW CYTOMETRY; HIV-1; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34848914044     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.192     Document Type: Article

References (31)

1. Galat A. Peptidylproline cis-trans-isomerases: immunophilins. Eur. J. Biochem. 216 (1993) 689-707
2. Gothel S.F., and Marahiel M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol. Life Sci. 55 (1999) 423-436
3. Liu J., Albers M.W., Wandless T.J., Luan S., Alberg D.G., Belshaw P.J., Cohen P., MacKintosh C., Klee C.B., and Schreiber S.L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31 (1992) 3896-3901
4. Allain F., Vanpouille C., Carpentier M., Slomianny M.C., Durieux S., and Spik G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. USA 99 (2002) 2714-2719
5. Sherry B., Yarlett N., Strupp A., and Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc. Natl. Acad. Sci. USA 89 (1992) 3511-3515
6. Xu Q., Leiva M.C., Fischkoff S.A., Handschumacher R.E., and Lyttle C.R. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267 (1992) 11968-11971
7. Seko Y., Fujimura T., Taka H., Mineki R., Murayama K., and Nagai R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 317 (2004) 162-168
8. Damsker J., Bukrinsky M.I., and Constant S.L. Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J. Leuk. Biol. 82 (2007) 613-618
9. Jin Z.G., Melaragno M.G., Liao D.F., Yan C., Haendeler J., Suh Y.A., Lambeth J.D., and Berk B.C. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 87 (2000) 789-796
10. Yurchenko V., Zybarth G., O'Connor M., Dai W.W., Franchin G., Hao T., Guo H., Hung H.C., Toole B., Gallay P., Sherry B., and Bukrinsky M. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277 (2002) 22959-22965
11. Yurchenko V., O'Connor M., Dai W.W., Guo H., Toole B., Sherry B., and Bukrinsky M. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 288 (2001) 786-788
12. Bukrinsky M.I. Cyclophilins: unexpected messengers in intercellular communications. Trends Immunol. 23 (2002) 323-325
13. Pushkarsky T., Zybarth G., Dubrovsky L., Yurchenko V., Tang H., Guo H., Toole B., Sherry B., and Bukrinsky M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl. Acad. Sci USA 98 (2001) 6360-6365
14. Pakula R., Melchior A., Denys A., Vanpouille C., Mazurier J., and Allain F. Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. Glycobiology 17 (2007) 492-503
15. S. Boulos, B.P. Meloni, P.G. Arthur, C. Bojarski, N.W. Knuckey, Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury, J. Neurosci. Res. (2007) PMID: 17663478.
16. Li M., Zhai Q., Bharadwaj U., Wang H., Li F., Fisher W.E., Chen C., and Yao Q. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106 (2006) 2284-2294
17. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., and Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73 (1993) 1067-1078
18. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., and Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 372 (1994) 363-365
19. Colgan J., Yuan H.E., Franke E.K., and Luban J. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 70 (1996) 4299-4310
20. Franke E.K., Yuan H.E., and Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372 (1994) 359-362
21. Braaten D., Franke E.K., and Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70 (1996) 3551-3560
22. Sherry B., Zybarth G., Alfano M., Dubrovsky L., Mitchell R., Rich D., Ulrich P., Bucala R., Cerami A., and Bukrinsky M. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc. Natl. Acad. Sci. USA 95 (1998) 1758-1763
23. Saphire A.C., Bobardt M.D., and Gallay P.A. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18 (1999) 6771-6785
24. Saphire A.C., Bobardt M.D., and Gallay P.A. Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunol. Res. 21 (2000) 211-217
25. Connor R.I., Sheridan K.E., Ceradini D., Choe S., and Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185 (1997) 621-628
26. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., and Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature 381 (1996) 667-673
27. Alfano M., Pushkarsky T., Poli G., and Bukrinsky M. The B-Oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages. J. Virol. 74 (2000) 8767-8770
28. Pang L., Sawada T., Decker S.J., and Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270 (1995) 13585-13588
29. Berditchevski F., Chang S., Bodorova J., and Hemler M.E. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J. Biol. Chem. 272 (1997) 29174-29180
30. Bukrinskaya A., Brichacek B., Mann A., and Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV- 1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188 (1998) 2113-2125
31. Iordanskiy S., and Bukrinsky M. Reverse transcription complex: the key player of the early phase of HIV replication. Future Virol. 2 (2007) 49-64